Tumor necrosis factor blocking agents: a review. Part II: safety and recommendations

Blockade of tumor necrosis factor with monoclonal antibodies, has emerged as one of the most promising therapies in some autoimmune conditions as rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and Crohn's disease. They have shown effectiveness on reducing symptoms and modifyi...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Anales de medicina interna (Madrid, Spain : 1984) Spain : 1984), 2006-02, Vol.23 (2), p.86
Hauptverfasser:	Rodríguez Moreno, C, López Vázquez, P, Durán Parrondo, C, Tato Herrero, F, Lado Lado, F, Velasco González, M
Format:	Artikel
Sprache:	spa
Schlagworte:	Humans Immunologic Factors - adverse effects Immunologic Factors - therapeutic use Risk Tumor Necrosis Factor-alpha - antagonists & inhibitors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!